BioHarvest Sciences Inc. Common StockBHST
▼ NegativeCapitalrelevance
Q2 GAAP EPS and revenue missed analyst estimates.

BioHarvest Sciences reported second-quarter results that fell short of analyst expectations. The company posted a GAAP loss of $0.17 per share, missing estimates by $0.05. Revenue came in at $8.84 million, a 3.8% increase year-over-year, but missed the consensus forecast by $0.61 million.
BioHarvest Sciences Inc. Common StockQ2 GAAP EPS and revenue missed analyst estimates.